Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

449 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C

NCT00216775

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Department of Gastroenterology and Hepatology, Kyoto University Hospital Kyoto, Japan

Kitano Hospital Osaka, Japan

Osaka Red Cross Hospital Osaka, Japan

Wakayama Red Cross Hospital Wakayama, Japan

View Trial Details

Completed

An Efficacy, Pharmacokinetics, Safety and Tolerability Study of TMC435 as Part of a Treatment Regimen for Hepatitis C-Infected Patients

NCT01725529

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Beijing, China

Changchun, China

Changsha, China

Chengdu, China

View all 21 locations

View Trial Details

Completed

Drug-drug Interaction of BI 201335 and Microgynon

NCT01570244

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 1220.56.1 Boehringer Ingelheim Investigational Site Biberach, Germany

View Trial Details

Completed

A Study of The Relationship Between Drop in Hemoglobin and Sustained Virological Response in Patients With Chronic Hepatitis C Treated With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a)

NCT01585324

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Most, Czechia

View Trial Details

Completed

Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment

NCT00844272

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +22 more
Locations: Not specified

View Trial Details

Completed

Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone

NCT00433069

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +20 more
Locations: Service de Gastroentérologie et d'Hépatologie, University Hospital Geneva, Canton of Geneva, Switzerland

View Trial Details

Completed

Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa

NCT02439918

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
Locations: Not specified

View Trial Details

Completed

A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

NCT01783678

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +27 more
Locations: Darlinghurst, New South Wales, Australia

Sydney, New South Wales, Australia

Melbourne, Victoria, Australia

Parkville, Victoria, Australia

View all 24 locations

View Trial Details

Completed

Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)

NCT00727259

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)

NCT01011166

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details